z-logo
Premium
Increased γ‐globin gene expression in β‐thalassemia intermedia patients correlates with a mutation in 3′HS1
Author(s) -
Papachatzopoulou Adamantia,
Kaimakis Polynikis,
Pourfarzad Farzin,
Menounos Panagiotis G.,
Evangelakou Panagiota,
Kollia Panagoula,
Grosveld Frank G.,
Patrinos George P.
Publication year - 2007
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.20979
Subject(s) - intermedia , haplotype , thalassemia , biology , fetal hemoglobin , locus (genetics) , genetics , microbiology and biotechnology , globin , hemoglobinopathy , gene , hemoglobin , mutation , transition (genetics) , hemolytic anemia , allele , fetus , immunology , biochemistry , pregnancy , art , performance art , art history
We report a novel set of genetic markers in the DNaseI hypersensitive sites comprising the human β‐globin locus chromatin hub (CH), namely HS‐111 and 3′HS1. The HS‐111 (−21 G>A) and 3′HS1 (+179 C>T) transitions form CH haplotypes, which occur at different frequencies in β‐thalassemia intermedia and major patients and normal (nonthalassemic) individuals. We also show that the 3′HS1 (+179 C>T) variation results in a GATA‐1 binding site and correlates with increased fetal hemoglobin production in β‐thalassemia intermedia patients. In contrast, the HS‐111 (+126 G>A) transition, found in three normal chromosomes, is simply a rare polymorphism. We conclude that the CH haplotypes are useful genetic determinants for β‐thalassemia major and intermedia patients, while the 3′HS1 (+179 C>T) mutation may have functional consequences in γ‐globin genes expression. Am. J. Hematol., 2007. © 2007 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom